Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Cardiovascular Research, 2023
Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease

Davidsson P., Eketjäll S., Eriksson N. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Ocular Immunology and Inflammation, 2023
Non-Infectious Uveitis Secondary to Dupilumab Treatment in Atopic Dermatitis Patients Shows a Pro-Inflammatory Molecular Profile

Achten R., van Luijk C., Thijs J. et al.

Olink Target 96OphthalmologyDermatological DiseasesPathophysiologyAqueous Humor

eBioMedicine, 2023
Association between proteomic biomarkers and myocardial fibrosis measured by MRI: the multi-ethnic study of atherosclerosis

Bakhshi H., Michelhaugh S., Bruce S. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Biomedicines, 2023
Inflammatory Blood Signature Related to Common Psychological Comorbidity in Chronic Pain

Karshikoff B., Wåhlén K., Åström J. et al.

Olink Target 96NeurologyPatient StratificationPlasma

PROTEOMICS – Clinical Applications, 2023
Analytical validation of a multi‐protein, serum‐based assay for disease activity assessments in multiple sclerosis

Qureshi F., Hu W., Loh L. et al.

Olink FocusNeurologyPatient StratificationTechnical EvaluationSerum

Molecular Medicine, 2023
Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning

Patel M., Knauer M., Nicholson M. et al.

Olink Explore 3072/384Infectious DiseasesPatient StratificationPlasma

Respiratory Research, 2023
Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia

Palma Medina L., Babačić H., Dzidic M. et al.

Olink Target 96Infectious DiseasesPatient StratificationPlasma

Nature Metabolism, 2023
Proteogenomic links to human metabolic diseases

Koprulu M., Carrasco-Zanini J., Wheeler E. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologySerum

Nature Communications, 2023
11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial

Othonos N., Pofi R., Arvaniti A. et al.

Olink Target 48Immunological & Inflammatory DiseasesPathophysiologySerum

JCI Insight, 2023
Vitamin D3 and deconvoluting a rash

Ernst M., Evans S., Techner J. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma

Journal of Allergy and Clinical Immunology, 2023
Proteomic and transcriptomic screening demonstrates increased mast cell–derived CCL23 in systemic mastocytosis

Söderlund S., Boey D., van Midden W. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

Inflammation Research, 2023
Screening inflammatory protein biomarkers on premature infants with necrotizing enterocolitis

Dong H., Zhang L., Li B. et al.

Olink Target 96Other Diseases & SyndromesPatient StratificationPlasma

The Journal of Clinical Endocrinology & Metabolism, 2023
Disease Duration and Chronic Complications Associate With Immune Activation in Individuals With Longstanding Type 1 Diabetes

Ajie M., van Heck J., Janssen A. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

BJU International, 2023
Urine supernatant reveals a signature that predicts survival in clear‐cell renal cell carcinoma

Daza J., Salomé B., Okhawere K. et al.

Olink Target 96OncologyPatient StratificationPlasmaUrine

Frontiers in Genetics, 2023
Circulatory proteins relate cardiovascular disease to cognitive performance: A mendelian randomisation study

Huang J., Gill D., Zuber V. et al.

Olink Target 96CVDNeurologyPathophysiologyPlasma

Leukemia, 2023
Cognitive impairments correlate with increased central nervous system immune activation after allogeneic haematopoietic stem cell transplantation

Boberg E., Kadri N., Hagey D. et al.

Olink Target 96NeurologyPathophysiologyCSF

International Journal of Molecular Sciences, 2023
Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma

Sandström K., Ehrsson Y., Sellberg F. et al.

Olink Target 96OncologyPatient StratificationSerum

Gut, 2023
Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis

Leibovitzh H., Lee S., Raygoza Garay J. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum

Journal of Nanobiotechnology, 2023
Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment

Cano A., Esteban-de-Antonio E., Bernuz M. et al.

Olink Target 96NeurologyPatient StratificationPlasmaEV LysateCSF

Obesity Medicine, 2023
Biomarker screening in children and adolescents reveals that CUB domain-containing protein 1 is associated with obesity and that hepatocyte growth factor is associated with weight gain

Manell H., Shen Q., Chowdhury A. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

3144 publications